Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
Itzchak Levy, Anat Wieder-Finesod, Vladyslav Litchevsky, Asaf Biber, Victoria Indenbaum, Liraz Olmer, Amit Huppert, Orna Mor, May Goldstein, E G Levin, Tammy Hod, Carmit Cohen, Yaniv Lustig, Galia Rahav
Topics & Concepts
ImmunogenicityInterquartile rangeMedicineAdverse effectViral loadAntibodyImmunologyVirologyInternal medicineHuman immunodeficiency virus (HIV)SARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections Studiesvaccines and immunoinformatics approaches